Opportunity Information: Apply for PA 15 109
Apply for PA 15 109
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.846 Arthritis, Musculoskeletal and Skin Diseases Research.
- This funding opportunity was created on Feb 4, 2015 and posted on Feb 4, 2015.
- Applicants must submit their applications by Nov 6, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $300,000.00 in funding.
- Eligible applicants include: Special district governments Native American tribal governments (Federally recognized) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education County governments City or township governments Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses Small businesses State governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts Public housing authorities/Indian housing authorities.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp), Funding Opportunity Number PA 15-109, is a National Institutes of Health (NIH) discretionary grant opportunity administered through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). It is an administrative supplement program, meaning it is designed to add funds onto an existing, active, peer-reviewed NIAMS-supported research award rather than funding an entirely new standalone project. The core goal is to help investigators grow beyond the boundaries of a single funded project and move toward building a broader, more independent and sustainable research program.
The STAR Program is specifically aimed at promoting innovation by giving investigators room to pursue high-risk, high-reward directions that branch from, but still fit within, the broader scientific scope of their currently funded research. NIAMS frames this as a transition point: taking a well-defined, structured R01 project and using supplemental support to explore new opportunities, test emerging ideas, develop new approaches, or open up promising lines of inquiry that could later become the foundation for additional projects and longer-term programmatic research. In practice, it is meant to create breathing room for creative exploration that might be difficult to fund through the original project budget or that may be too early-stage to compete as a full independent application.
Eligibility is tied to investigator status and the nature of the parent award. The supplement targets early established investigators (EEIs), which NIAMS defines here as investigators who have successfully renewed their first NIAMS-supported R01. In other words, the intended audience is not brand-new investigators, but researchers who have reached an important milestone (a first R01 renewal) and are positioned to broaden their work into a larger program. Because this is an administrative supplement, the applicant generally must already hold the qualifying active NIAMS award that will receive the supplement funds, and the proposed supplemental activities must remain within the overall scope of that active project.
From an applicant organization standpoint, the opportunity lists a wide range of eligible applicants, including public and private institutions of higher education, nonprofits (including 501(c)(3) and non-501(c)(3) organizations), for-profit organizations (including small businesses and other for-profits), and multiple levels of government (state, county, city/township, special districts), as well as independent school districts and public housing authorities/Indian housing authorities. The eligibility language also explicitly includes various mission-focused and community-serving institution types and entities such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, and eligible federal agencies. Foreign institutions and non-U.S. components of U.S. organizations are not eligible to apply, although foreign components (as NIH defines them in its Grants Policy Statement) are allowed, which typically means certain kinds of international collaborations may be permissible when justified and compliant with NIH policy.
The funding activity category is Health, under CFDA number 93.846 (Arthritis, Musculoskeletal and Skin Diseases Research). The opportunity indicates there is no cost sharing or matching requirement. The listed award ceiling is $300,000, signaling the supplement can be substantial enough to support meaningful expansion activities, such as generating preliminary data, piloting a new direction, adding an enabling technology, or otherwise accelerating work that helps convert a successful project into a larger programmatic trajectory.
Key timing details show the announcement was posted and created on February 4, 2015, with an original and current closing date of November 6, 2017, and an archive date of December 7, 2017. That means this specific announcement is no longer open, but it remains useful as a reference for understanding NIAMS priorities and how similar administrative supplement programs may be structured.
For those seeking the original announcement text, the funding notice link is provided as http://grants.nih.gov/grants/guide/pa-files/PA-15-109.html. For access or technical issues, the contact listed is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the STAR from Projects to Programs (Admin Supp) opportunity (PA 15-109)?
Supplements to Advance Research (STAR) from Projects to Programs (Admin Supp), Funding Opportunity Number PA 15-109, is a National Institutes of Health (NIH) discretionary grant opportunity administered through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). It is offered as an administrative supplement, meaning it provides additional funds to an existing, active, peer-reviewed NIAMS-supported research award rather than funding a brand-new standalone project.
Is this a new grant or an add-on to an existing award?
This is an administrative supplement (an add-on). The intent is to add funds onto a qualifying, active NIAMS-supported research award. It is not described as a mechanism for funding an entirely new independent project separate from an existing award.
What is the main purpose of the STAR administrative supplement?
The core goal is to help investigators grow beyond the boundaries of a single funded project and move toward building a broader, more independent, and sustainable research program. NIAMS frames this as a transition point from a well-defined, structured project (such as an R01) toward more programmatic research development.
What kinds of research activities does STAR aim to support?
The program is aimed at promoting innovation by giving investigators room to pursue high-risk, high-reward directions that branch from, but still fit within, the broader scientific scope of their currently funded research. Examples described include exploring new opportunities, testing emerging ideas, developing new approaches, opening promising lines of inquiry, generating preliminary data, piloting a new direction, adding an enabling technology, or otherwise accelerating work that could later support additional projects and longer-term programmatic research.
Do the supplemental activities need to be related to the parent award?
Yes. Because this is an administrative supplement, the proposed supplemental activities must remain within the overall scope of the active parent project that would receive the supplement funds.
Who is the STAR supplement intended for?
The supplement targets early established investigators (EEIs). In this announcement, NIAMS defines EEIs as investigators who have successfully renewed their first NIAMS-supported R01. The stated intent is to support researchers who have reached that milestone and are positioned to broaden their work into a larger research program.
Do you need to already have a NIAMS award to apply?
Generally, yes. As an administrative supplement, the applicant typically must already hold the qualifying active NIAMS-supported award that will receive the supplement funds.
What NIH institute administers this opportunity?
The opportunity is administered through NIAMS (the National Institute of Arthritis and Musculoskeletal and Skin Diseases), which is part of the NIH.
What is the funding category and CFDA number listed for this opportunity?
The funding activity category is Health. The CFDA number listed is 93.846, identified as Arthritis, Musculoskeletal and Skin Diseases Research.
What is the maximum award amount (award ceiling)?
The listed award ceiling is $300,000.
Is cost sharing or matching required?
No. The opportunity indicates there is no cost sharing or matching requirement.
What types of organizations are eligible to apply?
The eligibility list includes a wide range of applicant organizations, including:
- Public and private institutions of higher education
- Nonprofits (including 501(c)(3) and non-501(c)(3) organizations)
- For-profit organizations (including small businesses and other for-profits)
- State, county, city/township governments, and special district governments
- Independent school districts
- Public housing authorities/Indian housing authorities
- Eligible federal agencies
- Mission-focused and community-serving institutions such as HBCUs, Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), and faith-based or community-based organizations
Are foreign institutions eligible to apply?
No. Foreign institutions and non-U.S. components of U.S. organizations are not eligible to apply under this announcement.
Are foreign components allowed?
Yes. The eligibility language indicates that foreign components (as NIH defines them in its Grants Policy Statement) are allowed. This typically implies certain international collaborations may be permissible when justified and compliant with NIH policy, even though foreign institutions cannot apply as the primary applicant.
When was this funding opportunity posted, and is it still open?
The announcement was posted/created on February 4, 2015. The original and current closing date listed is November 6, 2017, with an archive date of December 7, 2017. Based on those dates, this specific announcement is no longer open.
Where can the original funding announcement be found?
The funding notice link provided is: http://grants.nih.gov/grants/guide/pa-files/PA-15-109.html
Who is listed as a contact for access or technical issues?
The contact listed for access or technical issues is the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
What does NIAMS mean by moving from "projects to programs"?
In this description, NIAMS presents STAR as support for a transition point: using supplemental funds to expand beyond a single well-defined project (such as an R01) and explore new ideas and approaches that could become the foundation for additional projects and longer-term programmatic research.
Why would an investigator use this supplement instead of expanding within the existing project budget?
The announcement suggests the supplement is meant to create breathing room for creative exploration that might be difficult to fund through the original project budget, or that may be too early-stage to compete as a full independent application.
Browse more opportunities from the same category: Health
Next opportunity: Development and validation of laboratory procedures using next generation sequencing technologies to assess genes causing severe combined immune deficiency (SCID) in state newborn screening laboratories
Previous opportunity: Weed and Erosion Control Naval Observatory Flagstaff Station
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 15 109
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 15 109) also looked into and applied for these:
| Funding Opportunity |
|---|
| Development and validation of laboratory procedures using next generation sequencing technologies to assess genes causing severe combined immune deficiency (SCID) in state newborn screening laboratories Apply for RFA EH 15 002 Funding Number: RFA EH 15 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $350,000 |
| Medicare Rural Hospital Flexibility Grant Program Apply for HRSA 15 038 Funding Number: HRSA 15 038 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| HIV Early Intervention Services Program Existing Geographic Service Areas (EISEGA) Apply for HRSA 15 135 Funding Number: HRSA 15 135 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Patient Safety Learning Laboratories Innovative Design and Development to Improve Healthcare Delivery Systems (P30) Apply for RFA HS 15 001 Funding Number: RFA HS 15 001 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $1,000,000 |
| Rural Health Clinic Policy and Clinical Assessment Program Apply for HRSA 15 125 Funding Number: HRSA 15 125 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Phased Innovation Award for Exploratory Clinical Trials of Natural Products in NCCIH High Priority Research Topics (R21/R33) Apply for RFA AT 16 001 Funding Number: RFA AT 16 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Exploratory Clinical Trials of Natural Products in NCCIH High Priority Research Topics (R33) Apply for RFA AT 16 002 Funding Number: RFA AT 16 002 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01) Apply for PAR 15 115 Funding Number: PAR 15 115 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| FY15 The IPV Provider Network Engaging the Health Care Provider Response to Interpersonal Violence Against Women Apply for WH AST 15 001 Funding Number: WH AST 15 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $2,200,000 |
| Tuberculosis Health Action Learning Initiative (THALI) Apply for RFI 386 15 000001 Funding Number: RFI 386 15 000001 Agency: Agency for International Development Category: Health Funding Amount: $22,500,000 |
| Tuberculosis Call to Action (TBC2A) Apply for RFI 386 15 000002 Funding Number: RFI 386 15 000002 Agency: Agency for International Development Category: Health Funding Amount: $6,000,000 |
| Cooperative Agreements for Expansion and Sustainability of the Comprehensive Community Mental Health Services for Children with Serious Emotional Disturbances Apply for SM 15 009 Funding Number: SM 15 009 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $3,000,000 |
| Cooperative Agreement to Benefit Homeless Individuals for States Enhancement Apply for SM 15 010 Funding Number: SM 15 010 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $1,800,000 |
| Drug Free Communities Mentoring Program Apply for SP 15 002 Funding Number: SP 15 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $75,000 |
| Early Detection of Vision Problems in Young Children Apply for HRSA 15 084 Funding Number: HRSA 15 084 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIDCD Planning Grant for Phase III Clinical Trials in Communication Disorders (U34) Apply for PAR 15 117 Funding Number: PAR 15 117 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCD Phase I/II/III Clinical Trials in Communication Disorders (U01) Apply for PAR 15 116 Funding Number: PAR 15 116 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High End Instrumentation (HEI) Grant Program (S10) Apply for PAR 15 118 Funding Number: PAR 15 118 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Molecular Mechanisms of Combination Adjuvants (MMCA)(U01) Apply for RFA AI 15 005 Funding Number: RFA AI 15 005 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Improving the Health of People with Disabilities through State Based Public Health Programs DD12 1204 Apply for CDC RFA DD15 1502 Funding Number: CDC RFA DD15 1502 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 15 109", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.